Dr. Jim Bridge

The Evolution of Ozonated Glycerin: Updated Protocols, OG and DMSO Combined Therapy, and the Opportunities Defining the Next Decade

Presentation Description:
Ozonated glycerin has advanced rapidly, with new protocols, delivery strategies, and clinical applications emerging from frontline experience over the past year. In this presentation, Dr. Jim Bridge provides a comprehensive update on the latest developments in OG therapy, including protocol refinements, potency evaluation, and the growing integration of OG with DMSO. Attendees will explore how these advances are expanding possibilities in oncology support, chronic disease management, and other complex clinical cases. Designed for practitioners seeking to stay at the forefront of ozone medicine, this session offers practical insights and a forward-looking perspective on the future of ozonated glycerin therapy.

Additional Featured Session

Jim Bridge, DVM, CVA, FAAO & Pam Holloway, RN, MS, ACIM, FAAO

Presentation Title:
The Future of Ozonated Glycerin Medicine: Sensitive Cases, Precision Dosing, and Building the Research Case Study System

Presentation Description:
As the use of ozonated glycerin continues to expand, clinicians are increasingly challenged by complex patient populations, individualized dosing needs, and the demand for stronger clinical evidence. In this collaborative session, Dr. Jim Bridge and Pam Holloway examine the use of OG in sensitive and environmentally burdened patients, including those with mold exposure, Lyme disease, and chronic complex illnesses. The presentation will explore precision dosing strategies based on oxidative and redox status while introducing a new research case study framework designed to help practitioners contribute real-world clinical outcomes to a growing body of evidence. Attendees will gain practical tools for patient management while helping shape the future of ozonated glycerin medicine.